Skip to main content

Table 3 Down-regulated miRNAs (n=27) reported in at least two expression profiling studies

From: Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance

miRNA name Studies with same direction (reference) No. of tissue samples tested Mean fold-change Mean rank
hsa-miR-217 AE, AS, NA, NB, YN 371 18.16 4.20
hsa-miR-148a AE, AS, MB, NA, NB 371 8.03 7.00
hsa-miR-375 AE, AS, MB, NA, NB 371 4.86 9.40
hsa-miR-216b AS, NA, NB, YN 363 53.44 6.25
hsa-miR-216a AS, NA, NB, YN 363 30.17 2.25
hsa-miR-130b AE, AS, NA, NB 310 6.17 12.25
hsa-miR-141 NB, SZ, AE, AS 170 2.81 15.25
hsa-miR-30a-3p NA, NB, AE 212 2.71 30.67
hsa-miR-200c AE, AS, NB 150 2.66 23.67
hsa-miR-30a-5p AS, NB, AE 150 2.16 27.67
hsa-miR-29c AE, AS, NB 150 1.94 27.33
hsa-miR-30d AE, AS, NB 150 1.73 35.33
hsa-miR-30e AS, NB, AE 150 1.57 38.30
hsa-miR-379 SZ, AE, AS 122 1.62 21.67
has-miR-193b-3p NA, NB 208 6.67 20.50
hsa-miR-184 AS, YN 159 2.82 26.50
hsa-miR-338-5p AS, NB 142 3.15 25.50
hsa-miR-182 AE, AS 102 2.88 15.50
hsa-miR-30b AE, AS 102 2.25 17.00
hsa-miR-335 AE, AS 102 2.16 15.00
hsa-miR-200a AE, AS 102 1.66 24.50
hsa-miR-200b AE, AS 102 1.62 28.00
hsa-miR-30c AS, AS 98 2.18 17.00
hsa-miR-148b AE, MB 73 2.52 2.50
hsa-let-7f AE, SA 37 13.05 20.00
hsa-let-7c AE, SA 37 2.66 23.50
hsa-let-7b AE, SA 37 1.97 25.00